Literature DB >> 17178723

Two tyrosine residues of Toll-like receptor 3 trigger different steps of NF-kappa B activation.

Saumendra N Sarkar1, Christopher P Elco, Kristi L Peters, Saurabh Chattopadhyay, Ganes C Sen.   

Abstract

Innate immune response to viral infection is often triggered by Toll-like receptor 3 (TLR3)-mediated signaling by double-stranded (ds) RNA, which culminates in the activation of the transcription factor NF-kappaB and induction of NF-kappaB-driven genes. We demonstrated that dsRNA-induced phosphorylation of two specific tyrosine residues, 759 and 858, of TLR3 was necessary and sufficient for complete activation of the NF-kappaB pathway. When Tyr-759 of TLR3 was mutated, gene induction was inhibited, although NF-kappaB was partially activated. It was released from IkappaB and translocated to the nucleus but failed to bind to the kappaB site of the target A20 gene promoter. This defect could be attributed to incomplete phosphorylation of the RelA (p65) subunit of NF-kappaB, as revealed by two-dimensional gel analyses of p65, isolated from dsRNA-treated cells expressing either wild type TLR3 or the Tyr-759 --> Phe mutant TLR3. Thus, two phosphotyrosine residues of TLR3 activate two distinct pathways, one leading to NF-kappaB release and the other leading to its phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178723     DOI: 10.1074/jbc.C600226200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Toll-like receptors and leishmaniasis.

Authors:  Felipe F Tuon; Valdir S Amato; Hélio A Bacha; Tariq Almusawi; Maria I Duarte; Vicente Amato Neto
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

2.  Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection.

Authors:  John West; Blossom Damania
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

3.  Myeloid differentiation factor-2 interacts with Lyn kinase and is tyrosine phosphorylated following lipopolysaccharide-induced activation of the TLR4 signaling pathway.

Authors:  Pearl Gray; Jargalsaikhan Dagvadorj; Kathrin S Michelsen; Constantinos Brikos; Altan Rentsendorj; Terrence Town; Timothy R Crother; Moshe Arditi
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

4.  R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88.

Authors:  Yanbao Xiong; Chang Song; Greg A Snyder; Eric J Sundberg; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

5.  Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling.

Authors:  Michifumi Yamashita; Saurabh Chattopadhyay; Volker Fensterl; Paramananda Saikia; Jaime L Wetzel; Ganes C Sen
Journal:  Sci Signal       Date:  2012-07-17       Impact factor: 8.192

Review 6.  Tyrosine phosphorylation in Toll-like receptor signaling.

Authors:  Saurabh Chattopadhyay; Ganes C Sen
Journal:  Cytokine Growth Factor Rev       Date:  2014-06-21       Impact factor: 7.638

7.  The inducible nitric-oxide synthase (iNOS)/Src axis mediates Toll-like receptor 3 tyrosine 759 phosphorylation and enhances its signal transduction, leading to interferon-β synthesis in macrophages.

Authors:  Ming-Yu Hsieh; Miao Ying Chang; Yen-Jen Chen; Yung Kuo Li; Tsung-Hsien Chuang; Guann-Yi Yu; Chun Hei Antonio Cheung; Hui-Chen Chen; Ming-Chei Maa; Tzeng-Horng Leu
Journal:  J Biol Chem       Date:  2014-02-13       Impact factor: 5.157

Review 8.  Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Authors:  Elisabeth Vercammen; Jens Staal; Rudi Beyaert
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 9.  Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Chao-Qun Liu; Ying-Xiang Yang; Ping Lu; Shan-Feng Fu; Hui-Bin Qiu; Anthony E T Yeo
Journal:  J Biomed Biotechnol       Date:  2010-07-05

Review 10.  Intrinsic cellular defenses against virus infection by antiviral type I interferon.

Authors:  Kyung-Hyun Boo; Joo-Sung Yang
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.